Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_assertion description "[Taken together, these results suggest that erlotinib inhibits human NSCLC cell growth predominantly by inducing p27(KIP1) expression and by suppressing cell-cycle events involved in the G1/S transition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_assertion evidence source_evidence_literature NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_assertion SIO_000772 17456787 NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_assertion wasDerivedFrom befree-20150227 NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_assertion wasGeneratedBy ECO_0000203 NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.
- befree-20150227 importedOn "2015-02-27" NP845341.RA-WtwtxA-xtMnxAo7_qGnmfEvsDeGMuFYWXVuBC3CWk0130_provenance.